Health care company PainChek (ASX:PCK) is set to raise about AU$5.1 million through a fully underwritten non-renounceable, pro-rata entitlement offer to shareholders on the basis of one new share for every eight shares held, priced at $0.025 apiece, according to a Monday filing with the Australian bourse.
The offer comes with one free attaching new option, with an exercise price of AU$0.05 and a 12-month expiry, for every new share issued, the filing said.
The proceeds will support the expansion of ANZ and UK Adult App sales in aged care and home care sectors, North American market entry post US Food and Drug Administration clearance, completion of Infant App commercial launch, and financing preparation, according to the filing.
PainChek shares rose nearly 4% in afternoon trade Monday.
Price (AUD): $0.03, Change: $+0.001, Percent Change: +3.57%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。